End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
781,000 KRW | 0.00% | -0.51% | +2.76% |
05-06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
- Stock Market
- Equities
- A207940 Stock
- Charts Samsung Biologics Co.,Ltd.
- Total Return chart